126 related articles for article (PubMed ID: 10620729)
1. Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex.
Berton M; Allémann E; Stein CA; Gurny R
Eur J Pharm Sci; 1999 Dec; 9(2):163-70. PubMed ID: 10620729
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles.
Delie F; Berton M; Allémann E; Gurny R
Int J Pharm; 2001 Feb; 214(1-2):25-30. PubMed ID: 11282232
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers.
Zimmer A
Methods; 1999 Jul; 18(3):286-95, 322. PubMed ID: 10454987
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.
Aukunuru JV; Ayalasomayajula SP; Kompella UB
J Pharm Pharmacol; 2003 Sep; 55(9):1199-206. PubMed ID: 14604462
[TBL] [Abstract][Full Text] [Related]
5. Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres.
Gayakwad SG; Bejugam NK; Akhavein N; Uddin NA; Oettinger CE; D'Souza MJ
J Microencapsul; 2009 Dec; 26(8):692-700. PubMed ID: 19888878
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-TPP nanoparticle as a release system of antisense oligonucleotide in the oral environment.
Dung TH; Lee SR; Han SD; Kim SJ; Ju YM; Kim MS; Yoo H
J Nanosci Nanotechnol; 2007 Nov; 7(11):3695-9. PubMed ID: 18047039
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin loaded pH-sensitive microparticles.
Meissner Y; Ubrich N; Ghazouani FE; Maincent P; Lamprecht A
Int J Pharm; 2007 Apr; 335(1-2):147-153. PubMed ID: 17150317
[TBL] [Abstract][Full Text] [Related]
8. Alginate/poly-L-lysine microparticles for the intestinal delivery of antisense oligonucleotides.
González Ferreiro M; Tillman LG; Hardee G; Bodmeier R
Pharm Res; 2002 Jun; 19(6):755-64. PubMed ID: 12134944
[TBL] [Abstract][Full Text] [Related]
9. Preparation of a cationic nanoemulsome for intratumoral drug delivery and its enhancing effect on cellular uptake in vitro.
Li H; Xiao Y; Niu J; Chen X; Ping Q
J Nanosci Nanotechnol; 2011 Oct; 11(10):8547-55. PubMed ID: 22400223
[TBL] [Abstract][Full Text] [Related]
10. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
Lewis KJ; Irwin WJ; Akhtar S
J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: characterization of antisense oligonucleotides loaded copolymer nanoparticles.
Zobel HP; Stieneker F; Atmaca-Abdel Aziz S; Gilbert M; Werner D; Noe CR; Kreuter J; Zimmer A
Eur J Pharm Biopharm; 1999 Jul; 48(1):1-12. PubMed ID: 10477322
[TBL] [Abstract][Full Text] [Related]
12. A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes.
De Rosa G; Bochot A; Quaglia F; Besnard M; Fattal E
Int J Pharm; 2003 Mar; 254(1):89-93. PubMed ID: 12615416
[TBL] [Abstract][Full Text] [Related]
13. Electrochemical method for entrapment of oligonucleotides in polymer-coated electrodes.
Piro B; Pham MC; Ledoan T
J Biomed Mater Res; 1999 Sep; 46(4):566-72. PubMed ID: 10398018
[TBL] [Abstract][Full Text] [Related]
14. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
Lane ME; Brennan FS; Corrigan OI
Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
Devarajan PV; Sonavane GS
Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
[TBL] [Abstract][Full Text] [Related]
16. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
17. Characterization of alginate/poly-L-lysine particles as antisense oligonucleotide carriers.
González Ferreiro M; Tillman L; Hardee G; Bodmeier R
Int J Pharm; 2002 Jun; 239(1-2):47-59. PubMed ID: 12052690
[TBL] [Abstract][Full Text] [Related]
18. Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterization.
Lochmann D; Weyermann J; Georgens C; Prassl R; Zimmer A
Eur J Pharm Biopharm; 2005 Apr; 59(3):419-29. PubMed ID: 15760722
[TBL] [Abstract][Full Text] [Related]
19. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
Khan A; Sommer W; Fuxe K; Akhtar S
J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
[TBL] [Abstract][Full Text] [Related]
20. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.
De Rosa G; Quaglia F; La Rotonda MI; Appel M; Alphandary H; Fattal E
J Pharm Sci; 2002 Mar; 91(3):790-9. PubMed ID: 11920765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
